共 19 条
[1]
Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., Et al., Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetes Care., 35, pp. 1364-1379, (2012)
[2]
Treatment Algorithm for People with Type 2 Diabetes
[3]
Premix insulin: initiation and continuation guidelines for management of diabetes in primary care, J Assoc Physicians India, 57, pp. 42-46, (2009)
[4]
Sheu W.H., Rosman A., Mithal A., Chung N., Lim Y.T., Deerochanawong C., Et al., Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia: an Asian-Pacific perspective and expert recommendations, Diabetes Res Clin Pract., 92, pp. 312-321, (2011)
[5]
Guideline for Management of PostMeal Glucose in Diabetes
[6]
Wang J.-S., Tu S.-T., Lee I.-T., Lin S.D., Lin S.Y., Su S.L., Et al., Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring, Diabetes Metab Res Rev., 27, pp. 79-84, (2011)
[7]
Nakagami T., Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin, Diabetologia., 47, pp. 385-394, (2004)
[8]
Lawes C.M., Parag V., Bennett D.A., Suh I., Lam T.H., Whitlock G., Et al., Blood glucose and risk of cardiovascular disease in the Asia Pacific region, Diabetes Care., 27, pp. 2836-2842, (2004)
[9]
Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., Sekikawa A., Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study, Diabetes Care, 22, pp. 920-924, (1999)
[10]
Kalra S., Plata-Que T., Kumar D., Mumtaz M., Sondergaard F., Kozlovski P., Et al., Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs, Diabetes Res Clin Pract., 88, pp. 282-288, (2010)